Literature DB >> 24706347

Reproducibility of creatine kinase reaction kinetics in human heart: a (31) P time-dependent saturation transfer spectroscopy study.

Adil Bashir1, Robert Gropler.   

Abstract

Creatine kinase (CK) is essential for the buffering and rapid regeneration of adenosine triphosphate (ATP) in heart tissue. Herein, we demonstrate a (31) P MRS protocol to quantify CK reaction kinetics in human myocardium at 3 T. Furthermore, we sought to quantify the test-retest reliability of the measured metabolic parameters. The method localizes the (31) P signal from the heart using modified one-dimensional image-selected in vivo spectroscopy (ISIS), and a time-dependent saturation transfer (TDST) approach was used to measure CK reaction parameters. Fifteen healthy volunteers (22 measurements in total) were tested. The CK reaction rate constant (kf ) was 0.32 ± 0.05 s(-1) and the coefficient of variation (CV) was 15.62%. The intrinsic T1 for phosphocreatine (PCr) was 7.36 ± 1.79 s with CV = 24.32%. These values are consistent with those reported previously. The PCr/ATP ratio was equal to 1.94 ± 0.15 with CV = 7.73%, which is within the range of healthy subjects. The reproducibility of the technique was tested in seven subjects and inferred parameters, such as kf and T1 , exhibited good reliability [intraclass correlation coefficient (ICC) of 0.90 and 0.79 for kf and T1 , respectively). The reproducibility data provided in this study will enable the calculation of the power and sample sizes required for clinical and research studies. The technique will allow for the examination of cardiac energy metabolism in clinical and research studies, providing insight into the relationship between energy deficit and functional deficiency in the heart.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  31P MRS; adenosine triphosphate (ATP); creatine kinase; heart; image-selected in vivo spectroscopy (ISIS); reproducibility; saturation transfer; time-dependent saturation transfer (TDST)

Mesh:

Substances:

Year:  2014        PMID: 24706347      PMCID: PMC4106821          DOI: 10.1002/nbm.3103

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  41 in total

1.  31P NMR spectroscopy of the human heart at 4 T: detection of substantially uncontaminated cardiac spectra and differentiation of subepicardium and subendocardium.

Authors:  R S Menon; K Hendrich; X Hu; K Uğurbil
Journal:  Magn Reson Med       Date:  1992-08       Impact factor: 4.668

2.  Canine myocardial creatine kinase isoenzymes after chronic coronary artery occlusion.

Authors:  S W Sharkey; M M Murakami; S A Smith; F S Apple
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

3.  Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy.

Authors:  S H Smith; M F Kramer; I Reis; S P Bishop; J S Ingwall
Journal:  Circ Res       Date:  1990-12       Impact factor: 17.367

4.  Creatine kinase kinetics in diabetic cardiomyopathy.

Authors:  Y Matsumoto; M Kaneko; A Kobayashi; Y Fujise; N Yamazaki
Journal:  Am J Physiol       Date:  1995-06

5.  Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts.

Authors:  B L Hamman; J A Bittl; W E Jacobus; P D Allen; R S Spencer; R Tian; J S Ingwall
Journal:  Am J Physiol       Date:  1995-09

6.  31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure.

Authors:  S Neubauer; T Krahe; R Schindler; M Horn; H Hillenbrand; C Entzeroth; H Mader; E P Kromer; G A Riegger; K Lackner
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

7.  Alterations in the myocardial creatine kinase system during chronic anaemic hypoxia.

Authors:  M L Field; J F Clark; C Henderson; A M Seymour; G K Radda
Journal:  Cardiovasc Res       Date:  1994-01       Impact factor: 10.787

8.  Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure.

Authors:  L Nascimben; J Friedrich; R Liao; P Pauletto; A C Pessina; J S Ingwall
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

9.  Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters.

Authors:  R Tian; L Nascimben; R Kaddurah-Daouk; J S Ingwall
Journal:  J Mol Cell Cardiol       Date:  1996-04       Impact factor: 5.000

10.  Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function.

Authors:  A Sauter; M Rudin
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

View more
  13 in total

1.  31 P magnetic resonance fingerprinting for rapid quantification of creatine kinase reaction rate in vivo.

Authors:  Charlie Y Wang; Yuchi Liu; Shuying Huang; Mark A Griswold; Nicole Seiberlich; Xin Yu
Journal:  NMR Biomed       Date:  2017-09-15       Impact factor: 4.044

2.  Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome.

Authors:  William Todd Cade; Richard Laforest; Kathryn L Bohnert; Dominic N Reeds; Adam J Bittel; Lisa de Las Fuentes; Adil Bashir; Pamela K Woodard; Christina A Pacak; Barry J Byrne; Robert J Gropler; Linda R Peterson
Journal:  J Nucl Cardiol       Date:  2019-11-08       Impact factor: 3.872

3.  In vivo creatine kinase reaction kinetics at rest and stress in type II diabetic rat heart.

Authors:  Adil Bashir; Andrew R Coggan; Robert J Gropler
Journal:  Physiol Rep       Date:  2015-01-27

4.  Feasibility and repeatability of localized (31) P-MRS four-angle saturation transfer (FAST) of the human gastrocnemius muscle using a surface coil at 7 T.

Authors:  Marjeta Tušek Jelenc; Marek Chmelík; Wolfgang Bogner; Martin Krššák; Siegfried Trattnig; Ladislav Valkovič
Journal:  NMR Biomed       Date:  2016-01       Impact factor: 4.044

5.  Impaired cardiac and skeletal muscle bioenergetics in children, adolescents, and young adults with Barth syndrome.

Authors:  Adil Bashir; Kathryn L Bohnert; Dominic N Reeds; Linda R Peterson; Adam J Bittel; Lisa de Las Fuentes; Christina A Pacak; Barry J Byrne; W Todd Cade
Journal:  Physiol Rep       Date:  2017-02

6.  Cardiac work is related to creatine kinase energy supply in human heart failure: a cardiovascular magnetic resonance spectroscopy study.

Authors:  Refaat E Gabr; AbdEl-Monem M El-Sharkawy; Michael Schär; Gurusher S Panjrath; Gary Gerstenblith; Robert G Weiss; Paul A Bottomley
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-10       Impact factor: 5.364

7.  Localized rest and stress human cardiac creatine kinase reaction kinetics at 3 T.

Authors:  William T Clarke; Mark A Peterzan; Jennifer J Rayner; Rana A Sayeed; Mario Petrou; George Krasopoulos; Hannah A Lake; Betty Raman; William D Watson; Pete Cox; Moritz J Hundertmark; Andrew P Apps; Craig A Lygate; Stefan Neubauer; Oliver J Rider; Christopher T Rodgers
Journal:  NMR Biomed       Date:  2019-03-28       Impact factor: 4.044

8.  Two repetition time saturation transfer (TwiST) with spill-over correction to measure creatine kinase reaction rates in human hearts.

Authors:  Michael Schär; Refaat E Gabr; AbdEl-Monem M El-Sharkawy; Angela Steinberg; Paul A Bottomley; Robert G Weiss
Journal:  J Cardiovasc Magn Reson       Date:  2015-08-08       Impact factor: 5.364

9.  Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo31P-MR Spectroscopy Follow-Up Study.

Authors:  Veronique Deschodt-Arsac; Laurent Arsac; Julie Magat; Jerome Naulin; Bruno Quesson; Pierre Dos Santos
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240

10.  Creatine kinase rate constant in the human heart measured with 3D-localization at 7 tesla.

Authors:  William T Clarke; Matthew D Robson; Stefan Neubauer; Christopher T Rodgers
Journal:  Magn Reson Med       Date:  2016-08-31       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.